171.86
price up icon0.51%   0.88
 
loading
Precedente Chiudi:
$170.98
Aprire:
$171.22
Volume 24 ore:
1.52M
Relative Volume:
1.12
Capitalizzazione di mercato:
$22.56B
Reddito:
$1.53B
Utile/perdita netta:
$-214.69M
Rapporto P/E:
-97.65
EPS:
-1.76
Flusso di cassa netto:
$-43.68M
1 W Prestazione:
+3.94%
1M Prestazione:
+11.21%
6M Prestazione:
+6.17%
1 anno Prestazione:
+60.32%
Intervallo 1D:
Value
$169.90
$173.50
Intervallo di 1 settimana:
Value
$162.00
$173.50
Portata 52W:
Value
$92.14
$183.00

Natera Inc Stock (NTRA) Company Profile

Name
Nome
Natera Inc
Name
Telefono
650-249-9090
Name
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Name
Dipendente
4,434
Name
Cinguettio
@nateragenetics
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
NTRA's Discussions on Twitter

Confronta NTRA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
NTRA
Natera Inc
171.86 22.56B 1.53B -214.69M -43.68M -1.76
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
397.88 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
196.39 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
523.92 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
115.56 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
154.73 27.64B 15.50B 1.33B 2.16B 7.34

Natera Inc Stock (NTRA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-13 Iniziato RBC Capital Mkts Outperform
2025-01-23 Iniziato Barclays Overweight
2024-06-03 Ripresa Jefferies Buy
2024-04-08 Ripresa Craig Hallum Buy
2024-02-20 Downgrade Raymond James Strong Buy → Outperform
2023-12-29 Reiterato BTIG Research Buy
2023-12-14 Iniziato Guggenheim Buy
2023-12-13 Iniziato Wolfe Research Outperform
2023-11-13 Aggiornamento Raymond James Outperform → Strong Buy
2023-09-28 Iniziato Bernstein Mkt Perform
2023-07-05 Ripresa JP Morgan Overweight
2023-05-05 Iniziato UBS Buy
2023-01-18 Aggiornamento Raymond James Mkt Perform → Outperform
2022-08-25 Iniziato Credit Suisse Outperform
2022-04-25 Iniziato Stephens Overweight
2022-03-08 Iniziato Goldman Buy
2022-01-06 Ripresa Piper Sandler Overweight
2021-10-15 Ripresa Cowen Outperform
2021-06-15 Iniziato Raymond James Mkt Perform
2021-05-25 Iniziato Wells Fargo Overweight
2021-01-28 Iniziato Truist Buy
2020-10-08 Iniziato BTIG Research Buy
2020-09-28 Iniziato Morgan Stanley Overweight
2020-09-17 Iniziato SVB Leerink Outperform
2020-06-10 Ripresa Piper Sandler Overweight
2020-05-07 Aggiornamento JP Morgan Neutral → Overweight
2018-10-05 Iniziato JP Morgan Neutral
2018-07-05 Reiterato Piper Jaffray Overweight
2017-08-07 Reiterato Morgan Stanley Overweight
2016-11-10 Reiterato The Benchmark Company Buy
2016-05-23 Reiterato The Benchmark Company Buy
2016-05-11 Reiterato The Benchmark Company Buy
2016-04-19 Iniziato The Benchmark Company Buy
2015-09-28 Aggiornamento Wedbush Neutral → Outperform
2015-08-14 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2015-08-04 Iniziato Robert W. Baird Outperform
2015-07-27 Iniziato Morgan Stanley Equal-Weight
2015-07-27 Iniziato Piper Jaffray Overweight
2015-07-27 Iniziato Wedbush Neutral
Mostra tutto

Natera Inc Borsa (NTRA) Ultime notizie

pulisher
Jun 18, 2025

Natera Approves Equity Plan Amendment at Annual Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

DNA Testing Market Size, Share, and Forecast 2025-2033: Key - openPR.com

Jun 18, 2025
pulisher
Jun 17, 2025

Natera: Growth Likely To Moderate, Despite Signatera Test Medicare Coverage (NASDAQ:NTRA) - Seeking Alpha

Jun 17, 2025
pulisher
Jun 16, 2025

Non-Invasive Cancer Testing Market Forecast | Major Players: Guardant Health, Exact Sciences, Qiagen, Natera Inc. - openPR.com

Jun 16, 2025
pulisher
Jun 16, 2025

Where are the Opportunities in (NTRA) - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 13, 2025

Here's How Much You Would Have Made Owning Natera Stock In The Last 10 Years - Benzinga

Jun 13, 2025
pulisher
Jun 12, 2025

Insider Sell: Gail Marcus Sells 4,000 Shares of Natera Inc (NTRA) - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape - GlobeNewswire Inc.

Jun 12, 2025
pulisher
Jun 10, 2025

NTRA Q1 Earnings Call: Growth in Oncology and Women's Health Drives Guidance Increase - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : Natera, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 02 - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Prenatal Genetic Counselling Market 2025-2032: Top Trends & - openPR.com

Jun 10, 2025
pulisher
Jun 09, 2025

Natera at Goldman Sachs Conference: Strategic Growth and Expansion - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Natera at Goldman Sachs Conference: Strategic Growth and Expansion By Investing.com - Investing.com India

Jun 09, 2025
pulisher
Jun 05, 2025

Insider Sell: Steven Chapman Sells Shares of Natera Inc (NTRA) - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Colorectal Cancer Diagnostics Market Size To Boom with Top Key - openPR.com

Jun 05, 2025
pulisher
Jun 05, 2025

Natera stock gains after Leerink Partners reiterates outperform rating By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Natera's Signatera test to be covered under Medicare - MSN

Jun 05, 2025
pulisher
Jun 04, 2025

Medicare expands coverage for Natera’s Signatera MRD test By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Sector Update: Health Care - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Natera Inc (NTRA) Trading 4.28% Higher on Jun 4 - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Natera (NTRA) Gains Medicare Coverage for Genome-Based Cancer Te - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Natera stock gains after Leerink Partners reiterates outperform rating - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Natera's Signatera test to be covered under Medicare (NTRA:NASDAQ) - Seeking Alpha

Jun 04, 2025
pulisher
Jun 04, 2025

Natera, Inc. Announces Medicare Coverage for Signatera Genome - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Natera (NTRA) Secures Medicare Coverage for Signatera MRD Assay | NTRA Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Natera announces Medicare coverage for Signatera MRD assay - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Medicare expands coverage for Natera’s Signatera MRD test - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

Natera Announces Medicare Coverage for Signatera™ Genome | NTRA Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Natera Announces Medicare Coverage for Signatera ™ Genome - Business Wire

Jun 04, 2025
pulisher
Jun 04, 2025

Natera Announces Medicare Coverage for Signatera™ Genome - New Castle News

Jun 04, 2025
pulisher
Jun 03, 2025

Natera (NasdaqGS:NTRA) Showcases 94% Sensitivity In Pan-Cancer Signatera Genome Study - simplywall.st

Jun 03, 2025
pulisher
Jun 02, 2025

SignateraTM Genome Clinical Performance Highlighted at ASCO 2025 - GuruFocus

Jun 02, 2025
pulisher
May 31, 2025

Natera Inc.: Is The Recent Growth in Signatera Volumes Here To Stay? - Smartkarma

May 31, 2025
pulisher
May 27, 2025

Natera Inc (NTRA) Shares Up 3.07% on May 27 - GuruFocus

May 27, 2025
pulisher
May 26, 2025

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga

May 26, 2025
pulisher
May 24, 2025

When the Price of (NTRA) Talks, People Listen - news.stocktradersdaily.com

May 24, 2025
pulisher
May 23, 2025

Natera Reaches 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily

May 23, 2025
pulisher
May 22, 2025

Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting | NTRA Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

Natera raises 2025 revenue outlook to $1.94B-$2.02B with 26% growth target - MSN

May 22, 2025
pulisher
May 22, 2025

Transcript : Natera, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 10 - marketscreener.com

May 22, 2025
pulisher
May 19, 2025

Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN

May 19, 2025
pulisher
May 19, 2025

Stocks Showing Rising Market Leadership: Natera Earns 82 RS Rating - Investor's Business Daily

May 19, 2025
pulisher
May 18, 2025

There's Reason For Concern Over Natera, Inc.'s (NASDAQ:NTRA) Price - simplywall.st

May 18, 2025
pulisher
May 17, 2025

Natera (NASDAQ:NTRA) Rating Lowered to “Sell” at StockNews.com - Defense World

May 17, 2025
pulisher
May 17, 2025

Natera (NASDAQ:NTRA) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World

May 17, 2025
pulisher
May 16, 2025

Natera: The Clues In Q1 Earnings (NASDAQ:NTRA) - Seeking Alpha

May 16, 2025
pulisher
May 15, 2025

NTRA: Piper Sandler Raises Price Target for Natera | NTRA Stock News - GuruFocus

May 15, 2025

Natera Inc Azioni (NTRA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Natera Inc Azioni (NTRA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
May 28 '25
Sale
161.00
10,000
1,610,000
35,000
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
May 20 '25
Sale
153.90
10,000
1,539,000
45,000
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
May 15 '25
Sale
150.20
10,000
1,502,000
74,000
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
Jun 13 '25
Sale
165.85
5,000
829,250
30,000
Sheena Jonathan
CO-FOUNDER
Jun 18 '25
Sale
167.29
3,070
513,571
248,774
Sheena Jonathan
CO-FOUNDER
Jun 16 '25
Sale
164.55
3,000
493,649
37,282
diagnostics_research LH
$261.88
price up icon 0.19%
diagnostics_research WAT
$342.63
price up icon 0.96%
diagnostics_research MTD
$1,153.93
price up icon 0.74%
diagnostics_research DGX
$179.43
price down icon 0.19%
diagnostics_research IQV
$154.73
price up icon 0.08%
Capitalizzazione:     |  Volume (24 ore):